Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patient's Experience of Receiving Preoxygenation With the TTIM (Tube Tip in Mouth) Versus the Face Mask - a Cross-over Randomised Study

NCT07914296 is registered in ClinicalTrials.gov with Copenhagen University Hospital, Rigshospitalet as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07914296 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Patient's Experience of Receiving Preoxygenation With the TTIM (Tube Tip in Mouth) Versus the Face Mask - a Cross-over Randomised Study
Lead sponsor
Copenhagen University Hospital, Rigshospitalet
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
December 31, 2026
Enrollment
64 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

preoxygenation

Arms

As registered; 2 arms.

  • Tube Tip In the Mouth first ExperimentalPreoxygenation by Breathing via the tip of a tube hold in the mouth (= Tube Tip In the Mouth (TTIM)

    In this arm the subject receives oxygen via the tip of the tube in the mouth first - followed by via a face mask

  • Preoxygenation via Face mask first Active comparatorPreoxygenation via Face mask

    The subject has preoxygenation via Face mask first

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Comfort From the start of the preoxygenation-procedure until the end of the preoxygenation-procedure

    The participants reports on a 10-point scale from 1 = "Not uncomfortable at all" to 10 = Unbearable uncomfortable"

Lead sponsor's other trials

Copenhagen University Hospital, Rigshospitalet, most recent start first.